Identification and targeting of M-phase progression downstream of HER2 in trastuzumab-sensitive and -resistant breast cancer cell lines.
2014 ◽
Vol 32
(15_suppl)
◽
pp. 612-612
2013 ◽
2009 ◽
2018 ◽
2014 ◽
Vol 45
(1)
◽
pp. 393-400
◽
2015 ◽